TGVN Stock Overview
TGC Ventures International, Inc. operates early detection cancer clinics, using infra-red thermal imaging technology.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
TGC Ventures International, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| TGVN | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -1.1% | 0.6% |
| 1Y | n/a | 9.7% | 32.1% |
Return vs Industry: Insufficient data to determine how TGVN performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how TGVN performed against the US Market.
Price Volatility
| TGVN volatility | |
|---|---|
| TGVN Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: TGVN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine TGVN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | n/a | n/a |
TGC Ventures International, Inc. operates early detection cancer clinics, using infra-red thermal imaging technology. The technology is used as diagnosis to determine structure changes in tissues to detect breast cancer. The company was formerly known as National Detection Clinics, Ltd.
TGC Ventures International, Inc. Fundamentals Summary
| TGVN fundamental statistics | |
|---|---|
| Market cap | US$120.00 |
| Earnings (TTM) | -US$598.94k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs TGVN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TGVN income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$2.52k |
| Gross Profit | -US$2.52k |
| Other Expenses | US$596.42k |
| Earnings | -US$598.94k |
Last Reported Earnings
Jul 31, 2006
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did TGVN perform over the long term?
See historical performance and comparison